Accelerated memory decline in Alzheimer's disease with apolipoprotein ε4 allele

被引：44

作者：

Hirono, N ^{[1
]}

Hashimoto, M

Yasuda, M

Kazui, H

Mori, E

机构：

[1] Ehime Univ, Sch Med, Fac Hlth Sci, Dept Clin Neurosci, Shigenobu, Ehime 7910295, Japan

[2] Ehime Univ, Sch Med, Fac Hlth Sci, Dept Basic Neurosci,Hyogo Inst Aging Brain & Cogn, Shigenobu, Ehime 7910295, Japan

来源：

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES | 2003年 / 15卷 / 03期

关键词：

D O I：

10.1176/appi.neuropsych.15.3.354

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

To investigate a possible effect of the apolipoprotein (APOE) epsilon4 allele on memory decline in Alzheimer's disease (AD), we examined 64 AD patients with the APOE epsilon3/3, epsilon3/4, or epsilon4/4 allele using the Alzheimer Disease Assessment Scale-Cognitive subscale (ADAS-Cog) and its subtests at the initial examination and at the 1-year follow-up visit. One-year changes in the scores of the Word Recall subtest, Word Recognition subtest, and total ADAS-Cog were significantly correlated with the number of APOE epsilon4 alleles after controlling for the effects of age, sex, education, test interval, and baseline scores. Findings revealed that APOE epsilon4 allele is related to an accelerated memory decline in AD.

引用

页码：354 / 358

页数：5

共 39 条

[11] MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].

FOLSTEIN, MF ;

FOLSTEIN, SE ;

MCHUGH, PR .

JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198

[12] GENE DOSE OF THE EPSILON-4 ALLELE OF APOLIPOPROTEIN-E AND DISEASE PROGRESSION IN SPORADIC LATE-ONSET ALZHEIMERS-DISEASE [J].

FRISONI, GB ;

GOVONI, S ;

GEROLDI, C ;

BIANCHETTI, A ;

CALABRESI, L ;

FRANCESCHINI, G ;

TRABUCCHI, M .

ANNALS OF NEUROLOGY, 1995, 37 (05) :596-604

[13] APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD [J].

Geroldi, C ;

Pihlajamäki, M ;

Laakso, MP ;

DeCarli, C ;

Beltramello, A ;

Bianchetti, A ;

Soininen, H ;

Trabucchi, M ;

Frisoni, GB .

NEUROLOGY, 1999, 53 (08) :1825-1832

[14] Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease [J].

Growdon, JH ;

Locascio, JJ ;

Corkin, S ;

GomezIsla, T ;

Hyman, BT .

NEUROLOGY, 1996, 47 (02) :444-448

[15] Apolipoprotein E ε4 and the pattern of regional brain atrophy in Alzheimer's disease [J].

Hashimoto, M ;

Yasuda, M ;

Tanimukai, S ;

Matsui, M ;

Hirono, N ;

Kazui, H ;

Mori, E .

NEUROLOGY, 2001, 57 (08) :1461-1466

[16] The effect of APOE ε4 allele on cerebral glucose metabolism in AD is a function of age at onset [J].

Hirono, N ;

Hashimoto, M ;

Yasuda, M ;

Ishii, K ;

Sakamoto, S ;

Kazui, H ;

Mori, E .

NEUROLOGY, 2002, 58 (05) :743-750

[17] Apolipoprotein E: Non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease [J].

Holmes, C ;

Levy, R ;

McLoughlin, DM ;

Powell, JF ;

Lovestone, S .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 61 (06) :580-583

[18] Apolipoprotein E4 accelerates dementia and increases cerebrospinal fluid tau levels in Alzheimer's disease [J].

Kanai, M ;

Shizuka, M ;

Urakami, K ;

Matsubara, E ;

Harigaya, Y ;

Okamoto, K ;

Shoji, M .

NEUROSCIENCE LETTERS, 1999, 267 (01) :65-68

[19] Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease [J].

Kurz, A ;

Egensperger, R ;

Haupt, M ;

Lautenschlager, N ;

Romero, B ;

Graeber, MB ;

Muller, U .

NEUROLOGY, 1996, 47 (02) :440-443

[20] Longitudinal SPECT study in Alzheimer's disease:: relation to apolipoprotein E polymorphism [J].

Lehtovirta, M ;

Kuikka, J ;

Helisalmi, S ;

Hartikainen, P ;

Mannermaa, A ;

Ryynänen, M ;

Riekkinen, PS ;

Soininen, H .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (06) :742-746

← 1 2 3 4 →